Background {#Sec1}
==========

The low incidence of chronic non-communicable diseases such as cardiovascular diseases, metabolic disorders, and lower risk of a variety of cancers is associated with frequent consumption of plant-derived foods such as vegetables, fruits, tea, and herbs \[[@CR1]\]. "Horchata" (HRCH) is a heritage drink in Southern Ecuador and is consumed for its therapeutic uses. HRCH is also called "aguas frescas" or "agua de frescos" and is an herbal mixture infusion of 16 to 32 medicinal plants depending on their spatial and temporal availability. The species to prepare HRCH are generally traded in a group locally named as "atado", "manojo", "ramillete" or "tongo" that is boiled for 10 min and can be consumed cold or hot \[[@CR2]\].

HRCH is very popular in in Southern Ecuador particularly among the indigenous people who believe that the therapeutic effect of the drink is improved when plants locally known as "calientes" (warm) and "frías" (cold) are properly combined. The urban and rural people who consume horchata in Loja province report positive benefits.

Previous studies have shown that some culturally important plant species can treat circulatory, digestive, nervous, and respiratory disease; 66% of medicinal plant species are anti-inflammatory, and 51% are analgesics \[[@CR2]\]. These activities are related to protective effects because these chronic inflammation processes are related to carcinogenesis \[[@CR3]--[@CR8]\], while anti-inflammatory substances contribute to chemoprevention \[[@CR9]--[@CR14]\]. Cancer chemoprevention includes long-term administration of pharmacological or natural compounds to prevent or slow down the cancer development \[[@CR15]--[@CR19]\]. Antigenotoxic agents exhibit desirable chemotherapeutic effects and control cancer.

Studies of cytotoxicity and genotoxicity/antigenotoxicity are rapid methods to assess the innocuousness and possible beneficial effects of single compounds or complex mixtures and foods \[[@CR20], [@CR21], [@CR33], [@CR34]\]. The aim of this study is to evaluate the protective effects of this drink in southern Ecuador. We studied the cytotoxic capacity in tumor cells as a protector of DNA damage using genotoxic agents that follow different DNA damaging pathways including oxidation and alkylation.

Methods {#Sec2}
=======

Materials {#Sec3}
---------

The following reagents and chemicals were purchased from Sigma-Aldrich, [St. Louis,](https://www.google.com.ec/search?q=St.+Louis&stick=H4sIAAAAAAAAAOPgE-LUz9U3sLC0SK5U4gAxzcoryrW0spOt9POL0hPzMqsSSzLz81A4VhmpiSmFpYlFJalFxQDMHhGVQwAAAA&sa=X&ved=0ahUKEwi_-Zaa-fnTAhXJNiYKHb-iCfgQmxMIkQEoATAQ) USA: 2′-7′-dichlorofluorescin diacetate (H~2~DCFDA), balanced salt solution (HBSS), sodium hydroxide (NaOH), potassium chloride (KCl), sodium bicarbonate (NaHCO~3~), sodium phosphate dibasic anhydrous (NaHPO~4~), monobasic potassium phosphate (KH~2~PO~4~), disodium ethylenediaminetetraacetate dihydrate (Na~2~EDTA), dimethyl sulfoxide (DMSO), sodium chloride (NaCl), methanol, ethanol, peroxidemitomycin C, doxurrubicin, (±)-6 hydroxy-2,5,7,8 tetra-methylchromane-2-carboxylic acid (Trolox), 2 diphenyl-1-picrylhydrazyl (DPPH), 2,4,6, tris(2-pyridyl)-s triazine for spectrophometric determination (of Fe) (TPTZ), iron III chloride hexahydrate, gallic acid, Folin--Ciocalteu's reagent, and cytochalasin B. The Tris and UltraPure Agarose were purchased from Invitrogen, Carlsbad, California, USA. Roswell Park Memorial Institute (RPMI) 1640 medium, HAM-F12, fetal bovine serum (FBS), L--glutamine, antibiotic-antimycotic (100 units·mL^−1^ penicillin G, 100 μg·mL^−1^ streptomycin and 0.25 μg·mL^−1^ amphotericin B), phytohemagglutinin and formaldehyde were purchased from GIBCO, Grovemont Cir, Gaithersburg, MD USA. Sodium acetate trihydrate, fuming hydrochloric acid, acetic acid (glacial) and sodium carbonate were purchased from Merck KGaA, Darmstadt, Germany. Triton X-100, agarose (LMP), and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTS) for CellTiter 96® Aqueous One Solution Cell Proliferation Assay were purchased from Promega, [Madison, Wisconsin,](https://www.google.com.ec/search?q=Madison+Wisconsin&stick=H4sIAAAAAAAAAOPgE-LUz9U3MKswKilR4gAx08qNKrW0spOt9POL0hPzMqsSSzLz81A4VhmpiSmFpYlFJalFxQBvCdizQwAAAA&sa=X&ved=0ahUKEwj6pKbx-PnTAhXETSYKHdC3BIIQmxMImwEoATAN) USA. [Lymphocyte separation medium](http://cellgro.com/products/cell-culture-reagents/lymphocyte-separation-medium.html) was purchased from Lonza, [Basilea, Suiza](https://www.google.com.ec/search?q=Basilea+Suiza&stick=H4sIAAAAAAAAAOPgE-LSz9U3MCqrKjQyV-IAsQ2zTdK0tLKTrfTzi9IT8zKrEksy8_NQOFYZqYkphaWJRSWpRcUABHbPFEQAAAA&sa=X&ved=0ahUKEwjQu_m68frTAhUMwiYKHVzcBfEQmxMIkQEoATAU). The Anexin-V/IP kit (sc-4252), PVDF transfer membrane (sc-3723), Bcl-2 (C-21, sc-783), Bax (P-19, sc-526), pS46-TP53 (Ser 46, sc-101,764), p-73 (recognizes all p73 isoforms raised against H-79, sc-7957), pY99-TP73 (Tyr 99, sc-101,769), H2AX (C-20, sc-54,606), pS139-H2A.X (Ser 139, sc-517,348), p21 (187, sc-817), β-tubulin (D-10, sc-5274), goat anti-rabbit (sc-2004), and donkey anti-goat (sc-2020) were purchased from Santa Cruz Biotech, San Jose, California, USA. Goat anti-mouse (AP308P) and a chemiluminescence kit (Luminata Crescendo Western HRP substrate) were purchased from EMD-Millipore, Billerica, Massachusetts, USA.

Lyophilization of the samples {#Sec4}
-----------------------------

We used samples from the best-selling HRCHs mixtures \[[@CR2]\]. Nine different mixtures were prepared, and the compositions are detailed in Table [1](#Tab1){ref-type="table"}. The specimens were purchased from local markets in Loja, Ecuador and identified by Fani Tinitana, PhD. A voucher specimen was deposited in the Herbarium of Universidad Técnica Particular de Loja, Ecuador.Table 1Species used in different mixtures of HRCHs obtained from markets in Loja cityFamilySpeciesCommon nameVoucher specimenSamplesMorphological structure usedTherapeutic useReferencesHRCH 1HRCH 2HRCH 3HRCH 4HRCH 5HRCH 6HRCH 7HRCH 8HRCH 9Adoxaceae*Sambucus nigra* L*.*TiloFT1252**XXXXX**FAnti-flu, bronquitic, colds, febrifuge, diarrhea and headache.\[[@CR13], [@CR14]\]Amaranthaceae*Amaranthus hybridus* L*.*AtacoFTMAL006**XXXXX**I,LAnti-inflammatory, anti-flu, anti-hemorrhagic, astringent, healing, diuretic and tonic.\[[@CR14]\]*Iresine herbstii* Hook*.*EscancelFT0486**XXXXXXXXX**F,L,RAnti-inflammatory, anti-flu, analgesic, diuretic, toning and healing.\[[@CR14], [@CR15]\]Apiaceae*Foeniculum vulgare* Mill*.*HinojoFT0025t**XXXX**LAnti-inflammatory, digestive, conjunctivitis, diabetes and used in lactation.\[[@CR13], [@CR16]\]Asteraceae*Matricaria recutita* L*.*ManzanillaFT0014t**XXXXXXX**F,L,SAnti-inflammatory, anti-flu, anti-flatulence, anthelmintic, febrifuge, digestive, cramps, healing, insomnia. Wounds, burns and stimulating tonic\[[@CR14], [@CR17]\]Borraginaceae*Borago officinalis*BorrajaFT011MAL**XXXXXX**F,LAnti - inflammatory, anti-flu, cough, expectorant, febrifuge, circulation, sudorific, astringent, diuretic and hypocholesterolemiant.\[[@CR13], [@CR17]--[@CR19]\]*Symphytum officinale L.*Suelda consueldaFT1084**X**L,RAnti-inflammatory, demulcent, hypotensive, stimulating tissue and nerves, astringent, diuretic and hemostatic.\[[@CR17], [@CR20]\]Brassicaceae*Mathiola incana* (L.) W.T. AitonAlhelíFT1250**XX**F,LAnti-inflammatory, anti-flu, sedative, analgesic, cough and digestive.\[[@CR13], [@CR14]\]Cariophyllaceae*Dinathus caryophyllus L.*ClavelFT1253**XX**F,L,PAnti-inflammatory, analgesic, sedative and cough.\[[@CR14], [@CR21]\]Equisetaceae*Equisetum bogotense* KunthCola caballoFT031t**XXXXXX**L,SAnti-inflammatory, antiseptic, febrifuge and diuretic.\[[@CR14], [@CR18]\]*Equisetum giganteun* L.Cola caballoFT1009**X**L,SAnti-inflammatory, antiseptic, depurative, hepatic, cancer and cough.\[[@CR13], [@CR14]\]Geraniaceae*Pelargonium graveolens L'Her.ex. Aiton*Malva esenciaFT1258**XXXXXXXXX**F,LAnti-inflammatory, analgesic, febrifuge, diabetes, diarrhea, gallbladder and liver problems, digestive, gastric ulcers, wounds, burns, respiratory diseases, jaundice, infertility, and urinary stones.\[[@CR14], [@CR22], [@CR23]\]*Pelargonium odoratissimun (L)* L*'*Hér.Malva OlorosaFT016t**XX**F,LAnti-inflammatory, analgesic, carminative and toning.\[[@CR14], [@CR23]\]Lamiaceae*Melissa officinalis* L*.*ToronjilFT45MPAT**XXXXX**L,SAnti-inflammatory, analgesic, anti-spasmodic, anti-flu, diuretic, ulcerations, digestive, sedative, colds, colic, flatulence, allergies, sudorific, insomnia, heart problems, hemorrhoids and toning.\[[@CR14], [@CR19], [@CR24]\]*Mentha x piperita* L*.*Hierba buena, mentaFT1261**XXXX**L,SAnti-inflammatory, anti-flatulence, febrifuge, liver and gallbladder problems, nerves, cramps, antispasmodic and digestive.\[[@CR14], [@CR17], [@CR19]\]*Mentha spicata* L*.*Menta, hierba buena, menta negraFT1260**XXXXXX**L,SAnti-inflammatory, anti-espasmodic, anti-flatulence, digestive and colic.\[[@CR19], [@CR25]\]*Ocimun basilicum* L*.*Albahaca negraFT46TMPA**XX**F,LAnti-inflammatory, anti-espasmodic, anti-flatulence, analgesic cough, headache, ear, digestive, heart problems, nerves, stimulation of lactation and febrifuge.\[[@CR14], [@CR19]\]*Ocimum campechianum Mill.*Albahaca blancaFTa46TMPA**X**F,LAnalgesic, digestive, carminative, febrifuge, ocular cloud, menstrual colic and postpartum bath.\[[@CR13], [@CR14]\]Linnaceae*Linum usitatissimum* L*.*LinazaFT47TMPA**XXXXX**SeAnti--inflammatory digestive, hepatic and diuretic.\[[@CR14], [@CR26]\]Malvacea*Malva arborea (L.) Webb & Berthel.*Malva blanca, malva altaFT042MC**XXXXXXX**F,LDepurative, toning and cancer.\[[@CR13]\]*Malva parviflora* L*.*Malva alta,malva blancaFT015MCE**XXXX**F,LAnti-inflammatory, antidiarrheal, febrifuge, depurative, diuretic, cough, tonic, obesity and insect bites.\[[@CR14], [@CR19], [@CR27]\]Onagracea*Fuchsia hybrida* Hort. T. Ex. Siebert & VossPena pena grande, pena pena rojaFT1262**XX**PAnti-inflammatory, anti-flu, sedative, stomachache and toning.\[[@CR14]\]*Fuchsia loxensis* Kunth*.*Pena pena blanca rosadaFT1158**XXX**FCardiotonic, febrifuge and sedative.\[[@CR14]\]*Fuchsia magellanica* Lam.Pena pena moradaFT0147**XXXX**F,LSedative.\[[@CR14]\]*Oenothera rosea* L'Her. ex Aiton.ShulloFT53MPAT**XX**F,L,SAnti-inflamatory, digestive, diuretic and hepatic.\[[@CR14], [@CR28]\]Piperaceae*Peperomia inaequalifolia* Ruiz & Pav*.*Congona grandeFT1197**XX**F,L,SAnti-parasitic, antiperspirant, analgesic, cardiotonic, diuretic, hepatic, sedative earache and insomnia.\[[@CR14]\]Plantaginaceae*Plantago major* L*.*LlantenFT13t**XXXXXXXX**WAnti-inflammatory, anti- hemorrhagic, digestive liver problems, healing, wounds, insect bites and diuretic.\[[@CR14], [@CR19]\]Poaceae*Cymbopogon citratus* (DC) StapfHierba luisaFT011t**XXXXXXX**LAnti-flatulence, analgesic, digestive, sedative, expectorant, spasmolytic and diuretic.\[[@CR14], [@CR29]\]Proteaceae*Oreocallis grandiflora* (Lam.) R.Br.CucharilloFT04t**XX**FAnti-inflammatory, digestive, hepatic astringent\
and diuretic.\[[@CR13], [@CR14]\]Rosaceae*Rosa cymosa* TrattRosa simple rosada blancaFT274**XX**PAnti-flu, anti-scorbite, digestive, astringent and diuretic.\[[@CR30]\]Solanaceae*Solanum americanum* Mill.MortiñoFT36t**X**XFr, LAnti-inflammatory, analgesic, digestive, febrifuge, sedative and respiratory system.\[[@CR14], [@CR31]\]Tiliaceae*Triumfetta semitriloba Jacq.*CadilloFT39t**XXXXX**F,L,SAnti- inflammatory, analgesic, astringent, febrifuge and diuretic.\[[@CR14]\]Verbenaceae*Aloysia triphylla* RoyseCedrónFT1240**XXXX**F,L,SAnti- inflammatory anti-spasmodic, anti-neuralgic, analgesic, cardiotonic, digestive and chest and stomach tonic.\[[@CR14], [@CR32]\]*F* flower, *Fr* fruit, *I* Inflorescence, *L* leaf, *P* petal, *R* Root, *S* stalks, *Se* seed, *W* whole plant

The HRCHs were prepared according to the traditional methods of Loja, the plants were boiled for 10 min in distilled water and then cooled to an ambient temperature. They were then placed in a laminar flow cabinet and transferred to sterilized glass vials. The samples were freeze-dried in a lyophilizer LABCONCO model 7,754,047 for approximately 48 h. Finally, the samples were stored at 4 °C.

Phytochemical screening {#Sec5}
-----------------------

Phytochemical screening showed the presence of secondary metabolites (alkaloids, terpenoids, flavonoids, tannins, saponins, steroids, and quinones), primary metabolites (proteins, carbohydrates, fats), and oils using standard procedures \[[@CR41]\].

Analysis of total phenolic content {#Sec6}
----------------------------------

The total phenolic compounds were measured spectrophotometrically on a microplate reader (EPOCH 2 BioTek, BioTek Instruments Inc., Highland Park, Winooski, USA) according to the Folin-Ciocalteu's method. This was applied to a 96-well microplate assay using gallic acid as a calibration standard \[[@CR42]\]. A 50-μL aliquot of the different concentrations of HRCHs samples and standards were added to 150 μL of freshly prepared Folin--Ciocalteu reagent (1:4 *v*/v in distilled water) in a 96-well TR5003 cell culture plate (TrueLine, USA). After 10 min at 37 °C, 50 μL of the saturated solution of sodium carbonate was added to each well, and the plate was incubated for 10 min at 37 °C. The absorbance of each solution was measured at 725 nm on a microplate reader (EPOCH 2 BioTek, BioTek Instruments Inc.). The standard curve was linear between 2 and 0.03 mM gallic acid solution. The total amount of phenolics was calculated as mg gallic acid equivalent (GAE)/g of sample.

DPPH radical scavenging assay {#Sec7}
-----------------------------

The DPPH free radical scavenging activity was evaluated on a microplate analytical assay according to the literature \[[@CR42], [@CR43]\]. A 30 mL aliquot of the different concentrations of freeze-dried samples and standard were added to 270 μL of DPPH in methanol solution (100 μM) in a 96-well microplate assay. After incubation at 20 °C for 60 min, the absorbance of each solution was determined at 515 nm using a microplate reader (EPOCH 2 BioTek, BioTek Instruments Inc.).

Ferric reducing antioxidant power (FRAP) assay {#Sec8}
----------------------------------------------

A FRAP assay was performed according to the literature \[[@CR42], [@CR44]\]. This was applied to a 96-well microplate assay while monitoring the reduction of Fe^3+^-TPTZ to blue-colored Fe^2+^-TPTZ. Stock solutions of acetate buffer (300 mM) pH 3.6, FeCl~3~·6H~2~O (20 mM) and 10 mM TPTZ in 40 mM in HCl (10 mM) were prepared. The fresh working solution was prepared by mixing ten volumes of acetate buffer, one volume TPTZ solution, and one volume FeCl~3~·6H~2~O solution. This was then warmed to 37 °C before use. The FRAP working solution (270 μL) was mixed and incubated with 30 μL HRCHs/standards for 30 min in the dark. The absorbance of each solution was measured at 593 nm using a microplate reader (EPOCH 2 BioTek, BioTek Instruments Inc.). The standard curve was linear between 400 and 25 μM Trolox™ solution.

Cells {#Sec9}
-----

Cerebral astrocytoma (D384) cells were kindly received from Dr. Mayra Paolillo at the University of Pavia. Colon cancer (RKO) were kindly received from Dr. Patricia Ostrosky at the Universidad Nacional Autonoma de Mexico. Prostate cancer (PC-3), breast cancer (MCF-7), lung cancer (A-549) and Chinese Hamster Ovary (CHO-K1) cells were purchased from the American Tissue Culture Collection (ATCC, Manassas, VA, USA).

Immortalized Chinese Hamster Ovary (CHO-K1) cells were cultured in HAM-F12 medium. The other cells were cultured in RPMI medium. These media were supplemented with 1% antibiotic-antimycotic, 2 mM L-glutamine, and 10% FBS. The cultures were maintained at 37 °C in a humid atmosphere at 5% CO~2~. The doubling times of the PC-3, MCF-7, RKO, and A-549 cells were established as 24 h; the CHO-K1 and D-384 cells were 16 h.

Human peripheral blood lymphocytes (PBL) were isolated by density gradient centrifugation with [lymphocyte separation medium](http://cellgro.com/products/cell-culture-reagents/lymphocyte-separation-medium.html) from whole peripheral blood from three donors. All donors gave informed written consent to use human blood samples for research purposes (View Ethics approval and consent to participate). The donors had the following characteristics: below age 30, healthy, non-smokers, and with unknown exposure to genotoxic chemicals or radiation. PBL were cultured at 37 °C and 5% CO~2~ in RPMI-1640 supplemented with 0.5% phytohemagglutinin; 1% antibiotic antimycotic, 2 mM L-glutamine, and 10% FBS. The cultures were maintained at 37 °C in a humid atmosphere at 5% CO~2~.

Cell viability assay {#Sec10}
--------------------

Cell viability was analyzed with a MTS assay to assess the viability and/or the metabolic state of the cancer cells based on mitochondrial respiratory activity. A total of 5 × 10^3^ cells were seeded into each well of 96-well plates and allowed to adhere for 24 h. After 24 h, the cells were treated with freeze-dried HRCHs at 50 μg·mL^−1^. Each concentration/assay was performed in triplicate. Negative control cells were treated with the DMSO vehicle to a final concentration of 0.1% *v*/v; 0.5 μM doxorubicin was used as a positive control. The cells were then incubated with the treatments for 48 h. After 48 h, MTS (5 mg·mL^−1^) was added, and the cells were further incubated for 2 h in the dark at 37 °C. Absorbance was measured at 492 nm versus a reference wavelength of 650 nm. In cell lines with a inhibition percentage over 30%, doses of 15, 45, 60, 75 and 100 μg·mL^−1^ of each HRCHs were applied, and the MTS assay was used to measure the inhibitory concentration 50 (IC~50~) using non-linear regression.

Annexin V-FITC/PI apoptosis assay {#Sec11}
---------------------------------

We next quantified apoptotic cells using an Annexin V-FITC/PI apoptosis detection kit \[[@CR45]\]. In brief, the D384 cells were seeded in 6-well plates at a density of 1 × 10^5^ cells/well. After treatment at the IC~50~ for 48 h, both adherent and floating cells were harvested and stained with Annexin V-FITC/PI according to the manufacturer's procedure. The samples were analyzed with fluorescence microscopy and an excitation wavelength of 475 nm (Zeiss Axioskop 2 plus); 200 cells were counted.

Western blotting analysis {#Sec12}
-------------------------

Total protein extraction, quantification, and immunoblots were performed as described \[[@CR46]\]. Briefly, 50 μg of total protein were separated by 12--15% SDS-PAGE and transferred to a PVDF membrane (IPVH00010, Immobilon-P, 0.45 μm, Millipore). Rabbit polyclonal antibodies against Bcl-2, Bax, pS46-TP53, p-73, and pY99-TP73 were used with mouse poyclonal antibodies against pS139-H2AX, p21, and β-tubulin and a goat polyclonal antibody against H2AX; all antibodies were used at the dilution factor recommended by the manufacturer with the appropriate goat anti-rabbit, goat anti-mouse, and donkey anti-goat horseradish peroxidase-conjugated immunoglobulins (1:5000). Immunoreactive bands were visualized using a chemiluminescence kit Luminata Crescendo Western HRP substrate. Quantitative analysis of the proteins used a C-Digit Blot Scanner (LICOR).

Measurement of reactive oxygen species (ROS) {#Sec13}
--------------------------------------------

The detection of ROS used 2′7´-dichlorodihydrofluorescein diacetate (DCHF-DA) \[[@CR47]\]. Previously, CHO-K1 cells were cultured in 96-well multi-plates in HAM-F12 culture medium supplemented for 16 h. The cells were incubated with H~2~DCFDA (20 μM) and HBSS for 30 min at 37 °C. The cells were exposed to doses of 1000 μg·mL − 1 of the HRCHs and/either H~2~O~2~ (5 mM) as a positive control; HBSS was applied as a negative control. The multiplate was incubated for 2 h at 37 °C. DCFDA fluoride was measured after exposure on a Fluoroskan Ascent (Thermo Fisher Scientific) fluorometer at a λ~ex~ of 485 nm and λ~em~ of 528 nm.

Alkaline comet assay {#Sec14}
--------------------

The alkaline comet assay was performed as reported elsewhere with minor modifications \[[@CR48]\]. After 16 h of culturing the CHO-K1, two experimental conditions were performed. The first was only HRCHs (1000 μg·mL^−1^), and the second was concurrent treatment for 16 h of HRCHs (1000 μg·mL^−1^) and H~2~O~2~ (5 mM). The CHO-K1 cell cultures were mixed with 150 μL low-melting agarose (0.5%) and added to microscope slides. The slides were immersed in a cooled lysing solution (10% DMSO, 1% Triton X-100, 2.5 M NaCl, 100 mM EDTA, and 10 mM Tris) for 12 h at 4 °C (pH 10). All steps after lysis were performed in the dark to prevent additional DNA damage by another factors. All slides were submerged in electrophoresis buffer solution (300 mM NaOH and 1 mM Na~2~EDTA) (pH 13) for 20 min; this allowed the DNA to unwind. Electrophoresis conditions were 25 V and 300 mA for 20 min. A buffer solution was used to neutralize the slides after electrophoresis, (0.4 M Tris, pH 7.5). Each slide received EtBr (60 μL, 30 μg·mL^−1^) with a cover glass. The length tail of DNA damage was estimated using a ZEISS-Axioskop 2 plus fluorescence microscope, and 100 cells were scored on each slide and confirmed with Comet assay VI software.

Micronucleus assay by cytokinesis-block (CBMN assay) {#Sec15}
----------------------------------------------------

The CBMN test was performed as reported elsewhere with minor modifications \[[@CR49]\]. After 16 h of culturing CHO-K1, three experimental conditions were performed. The first was only HRCHs and cytochalasin B at a final concentration of 2 μg/ml. The second was 24 h with HRCH, mytomicin C (MMC), and cytochalasin B. The last was MMC for 3 h followed by HRCHs and cytochalasin B. After 16 h of incubation, the cells were fixed in cold (−20 °C) ethanol 96° for 5 min washed with distilled water, re-fixed in acetic acid:methanol (1:3 *v*/v) for 5 min, and washed. The fixed cells were stained with a drop of DAPI (4′,6′-diamidino-2-phenylindole HCl, Serva), dissolved in Tris-buffer (pH 7.5) at 2 μg/ml. The preparations were evaluated with an Axioskop 2 plus microscope (Zeiss, Germany) equipped with a fluorescence illuminator (HBO50 lamp); the filter set was 365 nm excitation and 420 nm emission (specific for DAPI). Phase contrast was also used, and analysis was performed at high magnification for \~400 Å resolution. To facilitate discrimination of micronuclei (MN) and differentiation between mononucleated, binucleated (which divided once after exposition), and polynucleated cells (which divided twice or more). Scoring was performed blindly. The number of binucleated cells per dish was evaluated after scoring 2000 consecutive cells distributed as a monolayer according to the criteria described previously \[[@CR50]\].

Statistical analysis {#Sec16}
--------------------

All data were reported as the mean ± SEM of independent experiments. The statistical significance was obtained with one-way analysis of variance (ANOVA) followed by a Dunnet post-test; treated cultures were compared to controls. Statistical analyses were carried out in GraphPad Prism 4 (GraphPad Software, San Diego, CA).

Results {#Sec17}
=======

The results of phytochemical screening tests on freeze-dried HRCHs samples revealed the presence or absence of main secondary metabolites and other phytochemicals based on the presence or absence of expected color changes (Table [2](#Tab2){ref-type="table"}). The freeze-dried samples contained saponins, flavonoids (except HRCH 1), terpenoids (except HRCH 1), quinones (except HRCH 7 and HRCH 8), and alkaloids (except HRCH 2, HRCH 3 and HRCH 5).Table 2Preliminary phytochemical studies of HRCHsTestSampleHRCH 1HRCH 2HRCH 3HRCH 4HRCH 5HRCH 6HRCH 7HRCH 8HRCH 9Proteins------------------Carbohydrates------------------Fats------------------Alkaloids+----++--+++++++Terpenoids-Steroids--++++++++Flavonoids--++++++++Saponnins+++++++++Quinones++++++----+Tannins^a^--------+----+--+++ = Very positive, ++ = Strong positive, + = Fair positive, − = Absent^a^Type: pyrocatechol

The antioxidant capacity was measured because of the presence of flavonoids and quinones in almost all HRCH samples. The total phenolic contents (TPC) of the HRCHs were initially estimated as mg GAE/g of sample by employing the Folin-Ciocalteu method; values were between 106 and 147 GAE/g (Table [2](#Tab2){ref-type="table"}).

The antioxidant activity of nine HRCHs were evaluated in detail via DPPH and FRAP assays (Table [3](#Tab3){ref-type="table"}). The Trolox equivalent antioxidant capacity (TEAC) values were calculated as mmol Trolox equivalent (TE)/g of freeze-dried HRCH to confirm the high antioxidant capacity of seven of the nine HRCHs samples (\~1000 mmoles TE/g of freeze-dried) except HRCH 4 and HRCH 6. The ferric ion reducing capacity of the nine HRCHs was evaluated with total antioxidant capacity values ranging between 71 and 110 mmol TE/g of freeze-dried samples.Table 3Total phenolic content and total antioxidant capacity of the HRCHsSampleTPCDPPHFRAPmg GAE·g^−1^TEAC^a^ μmol TE·g^−1^TEAC^a^ μmol TE·g^−1^HRCH 1106.39 ± 0.11382.18 ± 27.771.35 ± 3.1HRCH 2147.32 ± 1.11126.91 ± 43.3105.51 ± 1.9HRCH 3143.40 ± 2.3999.64 ± 32.0101.65 ± 0.4HRCH 4128.39 ± 2.2230.96 ± 11.885.59 ± 2.0HRCH 5136.80 ± 2.2858.33 ± 37.996.82 ± 0.6HRCH 6143.03 ± 1.1584.23 ± 1.3103.23 ± 0.9HRCH 7138.17 ± 2.31092.36 ± 69.199.66 ± 6.9HRCH 8147.31 ± 2.21109.79 ± 31.9110.34 ± 1.4HRCH 9130.33 ± 1.1919.64 ± 46.686.21 ± 1.3^a^TEAC = Trolox equivalent (TE) antioxidant concentration

We used a MTS assay to evaluate the inhibitory activity of HRCHs on cell growth to determine whether HRCHs could affect tumor cell survival. There was no inhibitory effect on cell growth with PBL and CHO-K1 at 50 μg·mL^−1^ (Table [4](#Tab4){ref-type="table"}). None of the HRCHs inhibited growth by more than 30% in A-549, RKO, MCF-7, and PC-3 cell lines. In D-384 cells, five (HRCH 1, HRCH 2, HRCH 7, HRCH 8, and HRCH 9) of the 9 HRCHs generated cell inhibition greater than 30%.Table 4Cytotoxic effect of the HRCH*s* on cells exposed to 50 μg·mL^−1^Percentages of inhibition ± (SEM)Tumor humanImmortalized cellNormal Human cellLungAstrocytomaBreastProstateColonSampleA-549D-384MCF-7PC-3RKOCHO-K1PBLHRCH 11.7 ± 1.236.7 ± 4.0 ^(\*\*\*)^5.1 ± 1.014.7 ± 5.42.8 ± 0.7N.A.N.A.HRCH 21.9 ± 2.140.8 ± 14.3 ^(\*\*\*)^7.1 ± 1.3^(\*)^26.9 ± 6.6 ^(\*\*)^3.9 ± 2.12N.A.N.A.HRCH 31.6 ± 0.53.3 ± 1.60.3 ± 1.7N.A.0.4 ± 1.3N.A.N.A.HRCH 4N.A.2.0 ± 1.72.7 ± 1.8N.A.N.A.N.A.N.A.HRCH 5N.A.2.5 ± 1.74.6 ± 1.7N.A.N.A.N.A.N.A.HRCH 62.4 ± 4.6N.A.0.2 ± 1.2N.A.N.A.3.0 ± 0.3N.A.HRCH 7N.A.30.0 ± 0.7 ^(\*\*\*)^N.AN.A.4.1 ± 2.2^(\*)^N.A.N.A.HRCH 85.1 ± 1232.6 ± 5.0 ^(\*\*\*)^6.9 ± 0.08^(\*)^N.A.0.5 ± 1.5N.A.N.A.HRCH 94.4 ± 4.760.7 ± 0.04 ^(\*\*\*)^0.7 ± 0.22.2 ± 9.6N.A.N.A.N.A.Doxorubicin\
(0.5 μM)86.9 ± 6.2^(\*\*\*)^76.1 ± 2.6^(\*\*\*)^59.1 ± 7.4^(\*\*\*)^71.5 ± 1.5^(\*\*\*)^53.4 ± 3.6(\*\*\*)8.5 ± 0.3N.A*N.A.* No activity. Each data is given as the mean and its standard error (SEM) of at least three independent experiments. Data were analyzed by repeated ANOVA followed by Bonferroni post-test. Symbols denote statistically significant differences: \**p* \< 0.01, \*\**p* \< 0.001, and \*\*\**p* \< 0.0001 with respect to control and between HRCH

The data in Table [5](#Tab5){ref-type="table"} show the IC~50~ of the active HRCHs in D-348 cells. The IC~50~ range of effective HRCHs was 41 to 122 μg·mL^−1^. The least potent was HRCH 8 with 122.7 ± 4.3 μg·mL^−1^, and the most potent was HRCH 9 with 41.5 ± 6.2 μg·mL^−1^.Table 5Half maximal inhibitory concentration (IC~50~) of HRCHs on D384 cellsSampleIC~50~ ± SEM μg/mlAstrocytoma (D-384)HRCH 174.2 ± 0.7HRCH 298.7 ± 7.4HRCH 771.6 ± 1.8HRCH 8122.7 ± 4.3HRCH 941.5 ± 6.2Doxorubicin0.1 ± 0.2Each data is given as the mean and its standard error (SEM) of at least three independent experiments

We continued studies of the cytotoxic effect produced by the most prominent HRCHs whose IC~50~ are less than 80 μg·mL^−1^ (HRCH 1, HRCH 7, and HRCH 9). The D384 cells treated with negative control and IC~50~ of HRCHs for 48 h are shown in Fig. [1a](#Fig1){ref-type="fig"} including the morphological changes. Figure [2b](#Fig2){ref-type="fig"} shows fluorescence microscopy data for D384 cells using the Annexin V-PI assay. We observed a decrease in the percentage of viable cells as well as an increase in the percentage of cells in early apoptosis: HRCH 1 resulted in \~22% inhibition, HRCH 7 was \~27% and HRCH 9 was \~19%. In cells exposed to HRCH 9, there was an increase in the percentage of cells in late apoptosis (\~21%) compared with control cells (\~1%) (Fig. [1b](#Fig1){ref-type="fig"}). HRCHs can modulate proteins related to death by apoptosis after evaluating Bax (pro-apoptotic) and Bcl-2 (anti-apoptotic) proteins. In both HRCH 1 and HRCH 9, there was an increased Bax/Bcl-2 ratio with respect to the negative control. Both Bax and Bcl-2 increased in cells exposed to HRCH 7 (Fig. [2a-b](#Fig2){ref-type="fig"}).Fig. 1HRCH modulated morphological changes and induced apoptosis on D384 cells. **a** D384 cells were treated with control (C-), doxurrubicin (0.5 μM), HRCH 1 (74 μg·mL^−1^), HRCH 7 (71 μg·mL^−1^), and HRCH 9 (41 μg·mL^−1^) for 48 h. These were visualized under a microscope and imaged. Magnification: 40X. **b** Fraction of viable, apoptotic, and necrotic D384 cells treated with IC~50~ of HRCH for 48 h. Data are presented as mean ± SEM, *n* = 6. Data were analyzed by repeated ANOVA followed by Bonferroni post-test. Symbols denote statistically significant differences: \* *p* \< 0.01, \*\* *p* \< 0.001 and \*\*\* *p* \< 0.0001 with respect to C-; ^+^ *p* \< 0.01, ^++^ *p* \< 0.001 and ^+++^ *p* \< 0.0001 between HRCHs Fig. 2HRCHs modulated the expression of proteins on D-384 cells. D-384 cells were exposed to IC~50~ of HRCH 1, HRCH 7, and HRCH 9 for 48 h. **a** Total protein lysates were separated by 12--15% SDS-PAGE followed by western blot analysis with the indicated antibodies against p-73, pY99-TP73, pS46-TP53, Bcl-2, Bax, p21, γH2A.X, pS139-H2A.X and β-tubulin. **b** Quantitative analysis with software C-Digit Blot scanner. β-Tubulin was used as a loading control for total cell extracts

Accumulating evidence shows that p53 family members (p53, p63, and p73) play a fundamental role in the regulation of cell cycle arrest, apoptosis, autophagy, and metabolism in tumor cells exposed to stress-induced and DNA damaging agents of various origins \[[@CR51]--[@CR54]\]. Therefore, we examined whether HRCHs induced cell death and were implicated in the expression of these transcriptional factors in D384 cells. Fig. [2a-b](#Fig2){ref-type="fig"} show increased expression of p-73α and p-73β in all HRCHs (HRCH 1, HRCH 7 and HRCH 9) as well as a decrease in ΔNp-73 except for HRCH 7. It is also clear that this effect is modulated by phosphorylation of p53 when HRCH 1 and HRCH 7 are applied. In all cases, p21---a cell cycle arrest indicator---is activated. Fig. [2a-b](#Fig2){ref-type="fig"} increase with respect to the control of histones (γ-H2AX and p-γ-H2AX) related to DNA.

After observing DNA damage in tumor cells, we next studied if it occurred in normal cells using CHO-K1 cells serve as a model. We first studied the induction of ROS and subsequent genotoxicity damage and genotoxic and antigenotoxic activities. The CHO-K1 cells showed increased ROS (Fig. [3a](#Fig3){ref-type="fig"}), but this was \~50% lower than the values produced in a ROS-inducing agent (H~2~O~2~). Genotoxic and antigenotoxic activity were established with a comet assay and MNCB. Comet tail length was increased in CHO-K1 cells in all cases treatment with horchatas (Fig. [3b](#Fig3){ref-type="fig"}). However, relative to the H~2~O~2~ control, the DNA damage was \~ 30% (HRCH 9) and 40% (HRCH 1 and HRCH 7) lower.Fig. 3Production and inhibition of ROS, genotoxic, and anti-genotoxic activity on CHO-K1 cells exposed to HRCHs. **a** Reactive oxygen species of HRCHs with HRCHs (1000 μg·mL^−1^) and inhibition of ROS production with HRCHs (5 mM H~2~O~2~ + 1000 μg·mL^−1^). AUF: Arbitrary units of fluorescence. **b** Comet assay measured with tail length exposed to 1000 μg·mL^−1^ HRCHs and anti-genotoxic activity exposed to co-treatment with HRCH (1000 μg/ml) + 5 mM H~2~O~2~. **c** Number of Mn for 2000 BNC to 1000 μg·mL^−1^ HRCHs as well as anti-genotoxic activity exposed to co-treatment with HRCH μg·mL^−1^ + 1 mM MMC. The data are presented as the mean ± SEM, *n* = 6. Data were analyzed by repeated ANOVA followed by Bonferroni post-test. Symbols denote statistically significant differences: +++ *p* \< 0.0001 with respect to control (C-) and between HRCH samples. Symbols denote statistically significant differences: \* *p* \< 0.01, \*\* *p* \< 0.001, and \*\*\* *p* \< 0.0001 with respect to H~2~O~2~ and between HRCHs

When we measured the genotoxic damage via the MNBN test, we observed no increase with respect to basal damage via a DNA damage-inducing agent such as MMC. The damage decreases even at basal levels (Fig. [3c](#Fig3){ref-type="fig"}) with HRCHs. To determine if it is due to a direct interaction with the genotoxic agent and the components of the HRCHs, we used the inducing agent (MMC) for 3 h followed by HRCHs. The HRCH 7 maintained the antigenotoxic effect (Fig. [4](#Fig4){ref-type="fig"}).Fig. 4Anti-genotoxic activity on CHO-K1 cells exposed to HRCHs post-treatment with MMC. The number of Mn for 1000 BNC exposed to 1 mM MMC and 1000 μg·mL^−1^ HRCHs for 3 h. Data are presented as mean ± SEM, *n* = 6. Data were analyzed by repeated ANOVA followed by Bonferroni post-test. Symbols denote statistically significant differences: +++ *p* \< 0.0001 with respect to control (C-) and \*\*\* *p* \< 0.0001 with respect to MMC and between HRCHs

Discussion {#Sec18}
==========

This study describes the cytotoxicity activity of five horchata mixtures (HRCH 1, HRCH 2, HRCH 7, HRCH 8, and HRCH 9) on brain astrocytoma cells (D-384). This effect is not surprising because these products are sold as a traditional "brain tonic" \[[@CR2]\]. However, HRCHs have a high antioxidant capacity. The phenolic content is markedly higher than other plants \[[@CR21]\] and correlates well with the high antioxidant capacity of HRCHs. Likewise, HRCHs have a strong radical scavenging ability---even better than vitamins C and E \[[@CR55]\]. The antioxidant properties are protective against neuronal damage mediated by oxidative stress \[[@CR56]--[@CR59]\]. We emphasize that the same cytotoxic doses do not affect normal cells (CHO-K1 and PBL). This suggests that antioxidants in certain medicinal plants protect normal cells while killing neoplastic cells \[[@CR60], [@CR61]\]. The most potent mixtures (HRCH 1, HRCH 7, and HRCH 9) induce apoptosis, but the active ingredients are not clear because the product is a mixture. Some plants and their secondary metabolites have been previously described as inducers of apoptosis \[[@CR35]--[@CR59]\].

Post-translational modifications such as phosphorylation in the Serine 46/Tyrosine 99 of p53/P73 are critical because they facilitate binding with more affinity to pro-apoptotic proteins like Bax \[[@CR54]\]. Their overexpression increases the Bax/Bcl-2 ratio allowing the release of cytochrome C from mitochondria to promote apoptosis \[[@CR66]\]. Changes in protein expression are related to the percentages of early and late stages of apoptosis as can be seen in the differences between HRCH 7 and HRCH 9.

HRCHs inhibited ROS (in vitro in cells) and antigenotoxic (comet assay) and anticlastogenic (CBMN) effects. This could be due to an interaction with the genotoxic agents. However, when we tested different times between HRCHs and the alkylating agent, the anticlastogenic effect is maintained by HRCH 7 similar to various phytochemicals \[[@CR62]--[@CR65], [@CR67]--[@CR70]\]. Oxidative stress, chronic inflammation, and genomic instability events are predisposing factors for neoplastic transformation \[[@CR71]--[@CR73]\], and perturbation of these events may interfere with the malignant progression of cells. HRCH can enhance the genomic stability of cells and protect the cells against chromosomal and DNA damage induced by various genotoxic agents to gain insight into its potential use as a chemopreventive mixture.

Conclusions {#Sec19}
===========

Horchata is a traditional drink in southern Ecuador that contains various medicinal plants and cytotoxic activity toward astrocytoma cells inducing regulated apoptosis in the p53/p73 pathway. Several horchatas have antioxidant and anti-genotoxic capacity that could contribute to the protective effect of this beverage. However, deeper studies are needed to discern the possible synergistic or antagonistic interactions between the species used in traditional medicine.

CBMN assay

:   Cytokinesis-block micronucleus assay

CHO-K1

:   Chinese hamster ovary

DMSO

:   Dimethyl sulfoxide

DNA

:   Desoxyribonucleic acid

DOXO

:   Doxorrubicin

DPPH

:   2,2-diphenyl-1-picrylhydrazyl

EtBr

:   Ethidium Bromide

FRAP

:   Ferric ion reducing capacity

H~2~DCFDA

:   2′-7′-dichlorofluorescin diacetate

H~2~O~2~

:   Hydrogen Peroxide

HBSS

:   Hanks' Balanced Salt solution

HRCH

:   *horchata*

IC~50~

:   inhibitory concentration 50%

MMC

:   Mytomicin C

PBL

:   Human peripheral blood lymphocytes

PI

:   Propidium iodide

ROS

:   Reactive Oxygen Species

RPMI

:   Roswell Park Memorial Institute 1640 medium

TEAC

:   Trolox equivalent antioxidant capacity

TPC

:   Total Phenolic Contents
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